Company / Cash per Share
Voyager Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.19
FY2025
5-year range
$1.19 / $3.10
FY2021-FY2025
Trend
-26.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 3 consecutive years, from $3.10 in FY2022 to $1.19 in FY2025.
Based on SEC 10-K filings.
1.19 in FY2025 with a 5-year CAGR of -12.6%.
Declined from $1.78 to $1.19 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -27.2%
- 5-Year CAGR
- -12.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Voyager Therapeutics, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 26.4% year-over-year.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.19 | -26.4% |
| FY2024 | $1.62 | -9.0% |
| FY2023 | $1.78 | -42.5% |
| FY2022 | $3.10 | +10.8% |
| FY2021 | $2.79 | +19.7% |
| FY2020 | $2.33 | +61.2% |
| FY2019 | $1.45 | +45.0% |
| FY2018 | $1.00 | -30.2% |
| FY2017 | $1.43 | +407.3% |
| FY2016 | $0.28 | +70.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026